仿制药压境!砜吡草唑之后,组合化学要如何续写增长故事?
世界农化网中文网报道:近期,日本组合化学(Kumiai Chemical)公布了2026财年第二季度经营业绩。结合一季度数据来看,2026财年上半年(2025年11月至2026年4月)净销售额同比增长7%,营业利润同比增长11%,经常利润同比大增66%,归母净利润同比增长39%。
The Naming Patterns Behind 12,000 Biotech Companies
Earlier this month Labiotech published its roundup of the top biotech deals for May 2026. Heading the list was Angelini Pharma’s $4.1 billion acquisition of Catalyst Pharmaceuticals, just ahead of UCB’s acquisition of Candid Therapeutics for $2.2 billion. For its part, Lilly also acquired Curevo for $1.5 billion, and GSK took over at SiranBio for up to a billion in milestone payments. Meanwhile, in Labiotech’s summary of the top funding rounds in May, companies like Apogee Therapeutics ($1.3 billion), CellCentirc ($220 million), CREAT Medicines ($122 million), Cytospire Therapeutics ($83 million) and Accro Bioscience ($50 million) were five of the ten largest private biotech funding rounds in the world.
Novo Nordisk Foundation launches €60.2m European incubator for cardiometabolic drug discovery
The new programme, called CardioMetabolic Bridge, will be backed with DKK450m (€60.2m) over six years. It is designed to identify promising university research in areas such as obesity, diabetes and cardiovascular disease, and develop it into projects that could become new therapies, spinouts or assets attractive to pharmaceutical companies and investors.
TMR Management with FreshFoss under Warm Weather Conditions
Understanding TMR stability and intake: why warm weather challenges are back in focus for dairy farms.
EU reaches landmark Omnibus VI deal: Industry welcomes streamlined substance statutes
The European Council and European Parliament have reached a provisional interinstitutional agreement on the Omnibus VI package, a legal overhaul of cosmetic regulations in Europe presented by the European Commission (EC). The Council and Parliament are pushing to eliminate cosmetics containing carcinogenic, mutagenic, and reprotoxic substances (CMR) more quickly than the EC had proposed.
AMSilk Appoints Former Evolva CEO Christian Wichert as New Chief Executive
German biotech materials company AMSilk has named Christian Wichert as its new Chief Executive Officer. He succeeds Ulrich Scherbel, who will take on the role of Chief Operating Officer for AMSilk’s Premium Filaments division.
Solar Foods wins $89.2m backing for ‘protein from air’ factory, but final investment decision still pending
Finnish startup Solar Foods has just secured €77.8 million ($89.2 million) in grants and loans from Business Finland tow…
Here’s Why Regenerative Farming Is a Risk Management Story, Not an ESG Story
By Artem Milinchuk, Founder & Head of Strategy, FarmTogether, a farmland investment managerA new documentary is making the rounds. Groundswell — the third chapter in the trilogy
that began with Kiss the Ground — premiered at Cannes in May and launched on Amazon
Prime on World Environment Day (this past Friday, June 5th). Narrated by Demi Moore and
Woody Harrelson, I found it sweeping, cinematic, and genuinely compelling. It covers five
continents and makes a case for regenerative agriculture as a solution to soil loss, biodiversity
collapse, and climate change.
Jazz Pharmaceuticals inks $4bn cancer collab with Peter Thiel’s biotech project AbCellera
The companies said the preclinical research collaboration, option and license agreement will discover and develop next-generation T-cell engaging (TCE) multispecific antibodies. Involving up to five drug candidates, this could be the largest such deal struck by Jazz, and will be based around AbCellera’s antibody discovery technology. The partnership will work on optimised development candidates for multiple gastrointestinal (GI) cancers and other solid tumours.
Tech alone won’t future-proof the food system, experts warn
Governments and businesses have more tools than ever for spotting vulnerabilities in the food system before they trigger…
